HK1171193A1 - Composition comprising cnp or bnp for external preparation for skin for the treatment of dermatitis - Google Patents

Composition comprising cnp or bnp for external preparation for skin for the treatment of dermatitis

Info

Publication number
HK1171193A1
HK1171193A1 HK12112040.1A HK12112040A HK1171193A1 HK 1171193 A1 HK1171193 A1 HK 1171193A1 HK 12112040 A HK12112040 A HK 12112040A HK 1171193 A1 HK1171193 A1 HK 1171193A1
Authority
HK
Hong Kong
Prior art keywords
cnp
bnp
dermatitis
skin
treatment
Prior art date
Application number
HK12112040.1A
Other languages
English (en)
Inventor
Kyoko Endo
Original Assignee
Igisu Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igisu Co Ltd filed Critical Igisu Co Ltd
Publication of HK1171193A1 publication Critical patent/HK1171193A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
HK12112040.1A 2009-07-23 2012-11-23 Composition comprising cnp or bnp for external preparation for skin for the treatment of dermatitis HK1171193A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2009172589 2009-07-23
JP2010134600 2010-06-11
PCT/JP2010/062459 WO2011010732A1 (ja) 2009-07-23 2010-07-23 皮膚外用剤組成物

Publications (1)

Publication Number Publication Date
HK1171193A1 true HK1171193A1 (en) 2013-03-22

Family

ID=43499204

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12112040.1A HK1171193A1 (en) 2009-07-23 2012-11-23 Composition comprising cnp or bnp for external preparation for skin for the treatment of dermatitis

Country Status (15)

Country Link
US (4) US20120208756A1 (xx)
EP (1) EP2457581B1 (xx)
JP (5) JP4834190B2 (xx)
KR (2) KR101226165B1 (xx)
CN (4) CN110339346B (xx)
AU (1) AU2010274293B9 (xx)
BR (1) BR112012001491B1 (xx)
CA (1) CA2768810C (xx)
DK (1) DK2457581T3 (xx)
ES (1) ES2456502T3 (xx)
HK (1) HK1171193A1 (xx)
MX (1) MX2012001024A (xx)
NZ (1) NZ597797A (xx)
RU (2) RU2572694C2 (xx)
WO (1) WO2011010732A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2768810C (en) 2009-07-23 2014-05-20 Igisu Co., Ltd. Skin external-preparation composition
EP2666475B1 (en) 2011-01-21 2017-08-16 Igisu Co., Ltd. Therapeutic agent for alopecia
ES2488740B1 (es) * 2012-10-10 2015-06-11 J. Álvaro GALIANO RAMOS Formulación cosmética y dermatologica para el alivio del prurito
CN104367925A (zh) * 2014-11-07 2015-02-25 济南高达信息技术有限公司 一种治疗红皮病的中药洗剂及其制备方法
JPWO2016194855A1 (ja) * 2015-05-29 2018-06-07 株式会社 イギス 環状ペプチド並びに該環状ペプチドを含む医薬、外用剤および化粧料
RU2018102133A (ru) 2015-06-19 2019-07-19 Глобал Хелс Солюшенз, Ллк Композиции на основе вазелина, содержащие катионные биоциды
US20190119325A1 (en) * 2015-07-31 2019-04-25 Igisu Co., Ltd. Cnp cyclic peptide, and medicine, external preparation and cosmetic each containing said cyclic peptide
CN105617360B (zh) * 2015-12-04 2018-12-21 中国农业大学 C-型钠肽在制备外用避孕药和精子功能检测试剂中的应用
US20170290776A1 (en) * 2016-05-05 2017-10-12 Monosol Rx, Llc Pharmaceutical compositions with enhanced permeation
WO2018056907A1 (en) * 2016-09-21 2018-03-29 Agency For Science, Technology And Research Methods and compositions for inhibiting skin inflammation and determining cancer susceptibility
JP7125862B2 (ja) * 2018-05-29 2022-08-25 小林製薬株式会社 外用組成物
JP2019214520A (ja) * 2018-06-12 2019-12-19 花王株式会社 角層剥離改善剤
CN110302194B (zh) * 2019-07-23 2023-01-31 广州市皮肤病防治所(广州市性病防治监测中心) 一种具有抗炎和皮肤屏障保护作用的桉叶素联合糖皮质激素的复方制剂
US11419917B2 (en) 2020-04-07 2022-08-23 Drora Shevy Treatment for SARS-CoV-2 and other coronaviruses
JP7466939B2 (ja) 2022-08-31 2024-04-15 東洋ビューティ株式会社 Ｏ／ｄ相組成物及び水中油型乳化組成物

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114923A (en) 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
JP2809533B2 (ja) 1991-01-31 1998-10-08 壽之 松尾 Ｃｎｐ類似体ペプチド
JPH05207891A (ja) 1991-03-08 1993-08-20 Shionogi & Co Ltd 脳性ナトリウム利尿ペプチドの製造方法
AU6360394A (en) 1993-03-03 1994-09-26 Mayo Foundation For Medical Education And Research Vasonatrin peptide and analogs thereof
US6028055A (en) 1996-10-22 2000-02-22 Genetech, Inc. Receptor selective BNP
US5965533A (en) 1997-05-23 1999-10-12 Baxter International Inc. Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions
US6833358B1 (en) 1998-09-28 2004-12-21 Santen Pharmaceutical Co., Ltd. Lacrimal secretion promoters or eye drops for treating keratoconjunctival failure containing as the active ingredient natriuretic peptides
JP3799465B2 (ja) 1998-09-28 2006-07-19 参天製薬株式会社 ナトリウム利尿ペプチドを有効成分とする涙液分泌促進または角結膜障害治療用点眼剤
US6407211B1 (en) * 1999-12-17 2002-06-18 Mayo Foundation For Medical Education And Research Chimeric natriuretic peptides
IL142118A0 (en) 2001-03-20 2002-03-10 Prochon Biotech Ltd Method and composition for treatment of skeletal dysplasias
JP3676707B2 (ja) * 2001-07-18 2005-07-27 三菱電機株式会社 車両用交流発電機の固定子およびその製造方法
AU2003268531A1 (en) 2002-09-06 2004-03-29 University Of South Florida Materials and methods for treatment of allergic diseases
US20050271596A1 (en) 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US7648962B2 (en) * 2002-11-26 2010-01-19 Biocon Limited Natriuretic compounds, conjugates, and uses thereof
DE60331584D1 (de) 2002-11-26 2010-04-15 Biocon Ltd Modifizierte natriuretic verbindungen, konjugate und ihre verwendungen
US20040161435A1 (en) * 2003-02-14 2004-08-19 Gupta Shyam K. Skin Firming Anti-Aging Cosmetic Mask Compositions
EP1637162A4 (en) 2003-06-13 2009-07-15 Asubio Pharma Co Ltd MEDICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF IMMUNOLOGICAL ILLNESSES TH1 TYPE
DK1638443T3 (da) * 2003-06-20 2011-02-07 Mayo Foundation Isoformer af hjerne-natriuretisk peptid
CA2554599A1 (en) 2004-01-27 2005-08-11 Compugen Usa, Inc. Novel brain natriuretic peptide variants and methods of use thereof
JP2007525213A (ja) 2004-01-27 2007-09-06 コンピュゲン ユーエスエイ，インク． 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法
CA2561530C (en) 2004-03-31 2014-04-22 Kazuwa Nakao Therapeutic or prophylactic agent for arthritis
EP3446711A1 (en) 2004-03-31 2019-02-27 Kazuwa Nakao Composition for increasing body height
CA2576852A1 (en) * 2004-08-11 2006-02-23 Alza Corporation Apparatus and method for transdermal delivery of natriuretic peptides
EP1810716A1 (de) * 2005-12-23 2007-07-25 Deutsches Zentrum für Luft- und Raumfahrt e.V. Verfahren zur Bräunung der Haut
DE102004048576A1 (de) * 2004-10-04 2006-04-13 Deutsches Zentrum für Luft- und Raumfahrt e.V. Methode zur Bräunung der Haut
WO2008021872A1 (en) 2006-08-08 2008-02-21 Mayo Foundation For Medical Education And Research Diuretic and natriuretic polypeptides
WO2008032450A1 (fr) 2006-09-15 2008-03-20 Kyoto University Agent prophylactique et/ou thérapeutique pour une stéatose hépatique
US20120034183A1 (en) 2006-12-19 2012-02-09 Michael Cohen Compositions and methods for growing embryonic stem cells
JP5010913B2 (ja) * 2006-12-31 2012-08-29 寿子 小出 心房利尿ホルモンファミリー分子を活性物質として含有する組織再生製剤また該製剤をもちいる組織再生方法、および心房利尿ホルモンファミリー分子を活性物質として含有する発毛、増毛、育毛剤および皮膚組織修復改善剤また該製剤を用いる発毛、増毛、育毛促進方法および皮膚組織修復改善方法
JP2010168283A (ja) 2007-04-24 2010-08-05 Yamaguchi Univ ナトリウム利尿ペプチドを有効成分とする肝硬変・前癌病変の抑制剤
JP5207316B2 (ja) 2007-05-10 2013-06-12 国立大学法人名古屋大学 腹膜線維化抑制用医薬組成物
AU2008297411A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
WO2009043466A2 (en) 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Therapeutic use of the peptide gluten exorphin a5
JP2011504506A (ja) * 2007-11-21 2011-02-10 バイオマリン ファーマシューティカル インコーポレイテッド Ｃ型ナトリウム利尿ペプチドの変異体
US8741842B2 (en) 2008-07-02 2014-06-03 Mayo Foundation For Medical Education And Research Chimeric natriuretic polypeptides with unique pharmacologic profiles
US8642550B2 (en) * 2008-10-24 2014-02-04 Mayo Foundation For Medical Education And Research Chimeric natriuretic peptides without hypotensive inducing capability
US8150603B2 (en) 2008-11-26 2012-04-03 Caterpillar Inc. Engine control system having fuel-based timing
WO2010078325A2 (en) 2008-12-29 2010-07-08 Mayo Foundation For Medical Education And Research Natriuretic polypeptides for reducing or preventing restenosis
CA2758581C (en) * 2009-05-20 2022-06-14 Biomarin Pharmaceutical Inc. Variants of c-type natriuretic peptide
CA2768810C (en) 2009-07-23 2014-05-20 Igisu Co., Ltd. Skin external-preparation composition
JP2011024973A (ja) * 2009-07-24 2011-02-10 Mitsumasa Maeda 電子ペーパー付き便蓋
CN102596216B (zh) 2009-08-27 2016-04-20 远藤京子 鼻炎治疗剂
ITPG20090061A1 (it) 2009-11-27 2011-05-28 Andrea Marcantonini Impianto mobile per la produzione di calcestruzzo
EP2666475B1 (en) 2011-01-21 2017-08-16 Igisu Co., Ltd. Therapeutic agent for alopecia

Also Published As

Publication number Publication date
AU2010274293A1 (en) 2012-02-23
JP2016006058A (ja) 2016-01-14
CN105999230B (zh) 2022-06-24
CN102470163B (zh) 2016-06-15
KR101226165B1 (ko) 2013-01-24
JPWO2011010732A1 (ja) 2013-01-07
AU2010274293B8 (en) 2013-07-04
US20180099028A1 (en) 2018-04-12
CN104189893A (zh) 2014-12-10
US10946072B2 (en) 2021-03-16
JP6337071B2 (ja) 2018-06-06
CN104189893B (zh) 2018-10-23
KR101533695B1 (ko) 2015-07-06
CN102470163A (zh) 2012-05-23
EP2457581A1 (en) 2012-05-30
CN105999230A (zh) 2016-10-12
JP2012017316A (ja) 2012-01-26
CA2768810A1 (en) 2011-01-27
EP2457581A4 (en) 2012-12-12
KR20120049169A (ko) 2012-05-16
ES2456502T3 (es) 2014-04-22
CN110339346B (zh) 2023-06-27
RU2015150099A3 (xx) 2019-07-17
MX2012001024A (es) 2012-04-11
JP6055518B2 (ja) 2016-12-27
AU2010274293B2 (en) 2013-06-06
CN110339346A (zh) 2019-10-18
US20160250293A1 (en) 2016-09-01
RU2572694C2 (ru) 2016-01-20
DK2457581T3 (da) 2014-03-31
RU2012103653A (ru) 2013-08-27
BR112012001491B1 (pt) 2022-03-15
CA2768810C (en) 2014-05-20
JP2018135381A (ja) 2018-08-30
RU2015150099A (ru) 2017-07-27
US20120208756A1 (en) 2012-08-16
AU2010274293B9 (en) 2013-08-29
JP5778440B2 (ja) 2015-09-16
WO2011010732A1 (ja) 2011-01-27
KR20120130273A (ko) 2012-11-29
US9358269B2 (en) 2016-06-07
EP2457581B1 (en) 2014-01-08
JP2017061556A (ja) 2017-03-30
NZ597797A (en) 2013-11-29
JP4834190B2 (ja) 2011-12-14
US20140072520A1 (en) 2014-03-13
BR112012001491A2 (pt) 2020-01-28
US9968654B2 (en) 2018-05-15

Similar Documents

Publication Publication Date Title
HK1171193A1 (en) Composition comprising cnp or bnp for external preparation for skin for the treatment of dermatitis
IL259475A (en) Combined therapy for the treatment of diabetes
EP2654745A4 (en) COMPOSITION FOR TREATING SKIN CONDITIONS OF THE SKIN
EP2391208A4 (en) COMPOSITIONS FOR THE TREATMENT OF NAILS AND SKIN
ZA201208413B (en) Skin treatment composition
IL210810A0 (en) Compositions for the treatment of pain and/or inflamtion
HK1166305A1 (zh) 用於治療炎症的組合物及方法
ZA201200017B (en) Formulations for the treatment of deeep tissue pain
IL214133A0 (en) Skin treatment
GB0902040D0 (en) Composition for treatment of skin
EP2404592A4 (en) HAIR TREATMENT COMPOSITION
EP2627391A4 (en) HYDROPHOBIC CATHETER AND COMPOSITION
ZA201208568B (en) Skin treatment composition
IL200753A (en) Pharmaceutical preparation containing ib – meca for the treatment of psoriasis
HK1148958A1 (en) Aqueous solution of silybin glycocides and external skin treatment composition
HK1214771A1 (zh) 用於治療皮膚病的製劑
EP2437771A4 (en) COMPOSITIONS AND METHODS MODULATING MG29 FOR THE TREATMENT OF DIABETES
PT2637974T (pt) Composição multifuncional para o tratamento de desinfecção da água e utilização desta composição
ZA201005770B (en) The treatment of damaged skin
GB201010638D0 (en) Composition for treatment of skin
PL2456445T3 (pl) Środek do leczenia chorób skóry
GB0814043D0 (en) The treatment of skin disorders
GB2473735B (en) Skin treatment formulation
GB0901175D0 (en) The treatment of skin aging
GB201016836D0 (en) Composition for skin treatment